Worldover, AI operating system for substance-based businesses

    Cosmetics · R&D

    R&D software for cosmetic manufacturers

    Today

    A formulation works in the lab, then fails at 500kg, and the trial history that would explain why is spread across notebooks, spreadsheets and one chemist's memory.

    Generic project and lab tools record that a trial happened. They don't hold composition, use levels, restricted substance limits or the commercial constraints the formula has to satisfy, so feasibility is discovered late.

    With Worldover

    Worldover R&D connects trials, stability, compatibility and scale-up results to the formula version, the raw material specifications and the customer brief they belong to.

    Development output is a specification production can run and regulatory can defend, rather than a formula that needs re-proving.

    The problem

    Why generic R&D failscosmetics manufacturer teams.

    Trials are stored, not connected

    An ELN or shared drive records the result. It can't tell you that the winning trial used a raw material grade you're no longer buying.

    Cost and MOQ arrive after the science

    Formulators optimise performance, then discover that the material has a 500kg minimum order and a nine-week lead time, so the work is redone.

    Compliance is a review gate, not an input

    Restricted substances, allergen declarations and market limits are checked at the end, when a change is expensive rather than free.

    A working day

    A Thursday in the lab

    1. A customer asks for a sulphate-free variant of an existing cleanser at the same cost per unit.

    2. Today: the formulator starts from a copied spreadsheet, chases procurement for prices, and asks regulatory whether the new surfactant is acceptable in three markets.

    3. In Worldover: the existing formula is cloned as a new version with its cost, supplier and compliance context attached.

    4. Candidate surfactants show their price bands, MOQs, lead times and market restrictions while the formulator is still choosing.

    5. Stability and compatibility results attach to the trial, and the version that passes becomes the released specification without re-entry.

    How it runs

    How R&D worksinside Worldover.

    01

    Brief lands with its constraints

    Target cost, pack, market and claim requirements are visible in the lab, not held in the commercial team's inbox.

    02

    Trials build on the product record

    Every trial references composition, supplier grade and batch of raw material used, so results remain interpretable months later.

    03

    Stability and testing are tracked to completion

    Protocols, pull points and results sit on the version, with outstanding tests visible before anyone promises a launch date.

    04

    Scale-up carries the evidence forward

    Pilot and production trials link to the same version, so deviations at scale are diagnosed against known lab conditions.

    What's in it

    The detail behindR&D.

    EU CosIng

    R&D Lab Software

    Digital lab covering raw materials, formulations and regulatory screening.

    • Raw materials workflow management

      Build a raw material library with custom workflows across multiple material types, document types and field types, all defined by you during onboarding.

    • Composition management

      Add ingredients to raw materials as ranges or exact percentages, with full impurities management at ppm.

    • Table management

      Customisable views by coding system, part number, type or cost.

    • Complex cost management

      Manage raw material costs with customisable costing modules, currency settings and automatic currency conversion.

    • Gap analysis

      Reports showing which documents are present against which are missing.

    • Raw material administration

      Codes and sub-codes to organise the library the way your team already thinks.

    The difference

    Why the substance recordmakes the difference.

    Formulation is substance work. Worldover stores INCI, function, supplier grade, purity, allergen content and regulatory status on the material itself, so a chemist sees the constraint at the moment of choosing rather than at the review meeting. Change a supplier grade and every trial that used it's flagged.

    Willow

    What teams actually askonce the record is in one place.

    • Which trials used this raw material grade, and what were their stability outcomes?
    • Draft a comparison of the last three surfactant options we trialled, with cost per unit and market restrictions.
    • What is outstanding on stability for the products we plan to release next month?

    Willow doesn't replace expert judgment. It removes the searching, re-keying and chasing between the systems that hold your answers.